Authors


Meghan McGrath

Latest:

Assess healthcare leadership's ability to handle a crisis

If a crisis were to suddenly arise for your organization, would your people be ready to handle it?


Edmund J. Pezalla, MD, MPH

Latest:

Put drug development to work for diabetic patients

Although the diabetes pipeline is not large, we continue to have progress in meeting the unmet needs of patients with diabetes.


Kelly Rakowski

Latest:

Mend fragmented payer-provider relations: 4 tips

Payers and providers have traditionally operated on opposite sides of the tracks with limited collaboration, resulting in a disjointed and complicated experience for patients when accessing care.


Bryce Bach

Latest:

The potential effects of the proposed payer mergers

A deeper dive into the proposed payer mergers reveals how they could impact market dynamics.


Deborah Dorman-Rodriguez

Latest:

What should healthcare price transparency look like?

Health policy experts generally agree that properly tailored transparency tools can help to hold down prices. What is not settled at this point is what transparency should look like.


Nathaniel Lacktman

Latest:

Telehealth reimbursement under the microscope

In this commentary, attorney Nathaniel Lacktman shares why, in the era of payment reform, it is critical for health plans to provide telemedicine reimbursement.


Mary Claire Wohletz

Latest:

Why study international healthcare?

Those who are in decision-making roles must study how other countries address healthcare financing and delivery so as to bring the best initiatives of the studied country to the healthcare systems they oversee.


David Kaufman

Latest:

What should healthcare price transparency look like?

Health policy experts generally agree that properly tailored transparency tools can help to hold down prices. What is not settled at this point is what transparency should look like.


Craig Kasten

Latest:

Four reasons payers need to embrace the digital economy

Consumer and provider expectations have changed as a result of the digital economy. Here are four reasons why payers need to start migrating their businesses in that direction.


Amy Hampton

Latest:

Three tools for successful risk-based pharma negotiations

Biopharmaceutical manufacturers’ at-risk day is coming. Here’s how to prepare.



Scott Maratea

Latest:

Commercial payers: Don't leave money on the table

To put more risk-based dollars in the bank, payers need to master a new level of gathering and reporting on not just claims data, but clinical data as well.


Joseph M. Mack, MPA

Latest:

Meaningful Use final rule: 4 Tips for hospitals

Hospitals and physicians must be diligent in the implementation of their meaningful use business or strategic plan.



Karla Koertner, PMP

Latest:

CMS' mandatory bundled payment model: How to prepare

The Comprehensive Care for Joint Replacement (CCJR), has organizations’ leadership wondering how they will be able to perform in such a model. Here are some tips.


Shan Padda

Latest:

Five attributes of health plans poised to win

Today’s value-focused economy was a primary discussion point at a recent roundtable of health plan CEOs. The discussion led to five essential attributes that organizations must embrace to thrive.


Tina Wardrop, MHA, MSSW

Latest:

Super clinically integrated networks: 8 components to consider

Clinically Integrated Networks (CINs) are evolving quickly across the country in response to changing reimbursement trends and the move to value-based payments.


Susan Corneliuson, MHS, FACHE

Latest:

Super clinically integrated networks: 8 components to consider

Clinically Integrated Networks (CINs) are evolving quickly across the country in response to changing reimbursement trends and the move to value-based payments.


Bryant Furlow

Latest:

Will biosimilars deliver on expectations?

This might be the year when it becomes clear, perhaps painfully so, whether or not biosimilars can deliver on cost savings expectations.


Karen Marinella

Latest:

Mastering interviews: Tips for managed care executives

Tips to help healthcare executives present their most authentic selves during remote interviews.


R. Dale Grimes

Latest:

Proposed healthcare payer mergers are under review

Federal antitrust officials are determining how, and if, transactions will move forward. Here's a roadmap of what's ahead in 2016.


David Birdsall, MD

Latest:

High-cost patient populations: 3 areas to address

The solution to succeeding in value-based reimbursement models is to start inside the hospital with high acuity patients and build the systems that support them.


Rob Graybill

Latest:

Four data analytics initiatives to implement now

Innovation will be necessary to compete for consumers in the new market environment. Using data effectively can help plans stand out.


Jordan Bazinsky

Latest:

Risk sharing grows in the Medicaid space

While forming risk-based entities among Medicaid providers could be an effective way to better manage the care of low-income populations, the risk of unintended consequences cannot be ignored. A key hedge against these consequences is better use of patient data.


Jeremy Earl

Latest:

Four considerations when moving to value-based payment

Here are four critical considerations that are integral to successful implementation of a value-based payment model.


Miranda Hester

Latest:

Imaging programs reduce costs

Unnecessary diagnostic tests are harmful to patients and costly for health plans.


Jamie J. Gooch

Latest:

US healthcare costs accelerate

Since posting its lowest annual growth rate in more than six years, the average cost of healthcare services accelerated in May and June.


Randy Killian

Latest:

Patient visits should go back to the basics

Sometimes in our technology-driven environment, we get into a fixed routine of the current standard of care for our patients. What would we see or hear if we saw our practice or facility through the eyes and ears of our patients?


Jill Wechsler

Latest:

How FDA Plans to Encourage More Biosimilar Uptake

The hope is that more biosimilars will lead to more access and more affordable medications, but biosimilar uptake is lagging. Here’s why and how FDA hopes to fix it.


Duane Harrington

Latest:

The Hospital of the Future: Balancing Risk, Revenue in Post-Pandemic World

Healthcare providers have increasingly entered into value-based contracts with payers in recent years because they offer the opportunity to increase revenue-the primary driver of change for any business.

© 2025 MJH Life Sciences

All rights reserved.